Related Experiment Video
Updated: Feb 8, 2026

Determination of Molecular Structures of HIV Envelope Glycoproteins using Cryo-Electron Tomography and Automated Sub-tomogram Averaging
Published on: December 1, 2011
CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications
Rita Azevedo1,2, Cristiana Gaiteiro1,2,3, Andreia Peixoto1,2,4
11Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal.
Abstract:
CD44 is a heavily glycosylated membrane receptor playing a key role in cell adhesion, signal transduction and cytoskeleton remodelling. It is also one of the most studied glycoproteins in cancer, frequently explored for stem cell identification, and associated with chemoresistance and metastasis. However, CD44 is a general designation for a large family of splicing variants exhibiting different degrees of glycosylation and, potentially, functionally distinct roles. Moreover, structural diversity associated with ambiguous nomenclature has delayed clinical developments. Herein, we attempt to comprehensively address these aspects and systematize CD44 nomenclature, setting milestones for biomarker discovery. In addition, we support that CD44 may be an important source of cancer neoantigens, most likely resulting from altered splicing and/or glycosylation. The discovery of potentially targetable CD44 (glyco)isoforms will require the combination of glycomics with proteogenomics approaches, exploring customized protein sequence databases generated using genomics and transcriptomics. Nevertheless, the necessary high-throughput analytical and bioinformatics tools are now available to address CD44 role in health and disease.
Insights
CD44, a key cell receptor, presents diverse forms in cancer, impacting treatment. Systematizing its nomenclature and exploring its glycosylation and splicing are crucial for discovering new cancer biomarkers and neoantigens.
Area of Science:
- Molecular Biology
- Glycobiology
- Cancer Research
Background:
- CD44 is a heavily glycosylated membrane receptor involved in cell adhesion, signaling, and cytoskeleton organization.
- It is a significant target in cancer research, linked to cancer stem cells, chemoresistance, and metastasis.
- CD44 exists as a family of splicing variants with diverse glycosylation, leading to complex roles and nomenclature challenges.
Purpose of the Study:
- To comprehensively address CD44's structural diversity and systematize its nomenclature for biomarker discovery.
- To explore CD44 as a potential source of cancer neoantigens arising from altered splicing and glycosylation.
- To establish milestones for advancing CD44-related biomarker discovery in clinical settings.
Main Methods:
- Systematic review and analysis of CD44 structure, function, and nomenclature.
- Integration of glycomics with proteogenomics approaches.
- Utilizing customized protein sequence databases generated via genomics and transcriptomics.
Main Results:
- Identified structural diversity and ambiguous nomenclature as significant hurdles in CD44 clinical development.
- Proposed CD44 (glyco)isoforms as potential sources of cancer neoantigens due to altered splicing and glycosylation.
- Highlighted the availability of advanced analytical and bioinformatics tools for CD44 research.
Conclusions:
- Systematizing CD44 nomenclature is essential for unlocking its potential as a biomarker.
- Targeting specific CD44 (glyco)isoforms requires integrated glycomics and proteogenomics strategies.
- CD44 research holds promise for identifying novel cancer neoantigens and improving therapeutic strategies.
Related Concept Videos
Applications of Molecular Taxonomy
Clinical Applications of Epidermal Stem Cells
Local Anesthetics: Clinical Application as Spinal Anesthesia
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Matrix Proteoglycans and Glycoproteins
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...

